Abstract 4123: Clinical significance and the difference between programmed death-1 ligand-1 and ligand-2 in patients with esophageal cancer

Authors: Kazuo Okadome, Yoshifumi Baba, Taisuke Yagi, Yuki Kiyozumi, Kojiro Eto, Yukiharu Hiyoshi, Yohei Nagai, Takatsugu Ishimoto, Masaaki Iwatsuki, Shiro Iwagami, Yuji Miyamoto, Naoya Yoshida, Hideo Baba

Published: 2019-08-07

DOI: 10.1158/1538-7445.am2019-4123

Source: Full article